Literature DB >> 20671873

Prothrombin complex concentrates: an update.

Massimo Franchini1, Giuseppe Lippi.   

Abstract

Entities:  

Keywords:  PCC; over-anticoagulation reversal; prothrombin complex concentrate; thrombosis

Mesh：

Substances：

Year:  2010        PMID： 20671873      PMCID： PMC2906185          DOI： 10.2450/2010.0149-09

Source DB:  PubMed          Journal:  Blood Transfus        ISSN： 1723-2007            Impact factor:   3.443


× No keyword cloud information.
  44 in total

Review 1.  Guidelines on replacement therapy for haemophilia and inherited coagulation disorders in Italy.

Authors:  E Santagostino; P M Mannucci; A Bianchi Bonomi
Journal:  Haemophilia       Date:  2000-01       Impact factor: 4.287

2.  Suboptimal effect of a three-factor prothrombin complex concentrate (Profilnine-SD) in correcting supratherapeutic international normalized ratio due to warfarin overdose.

Authors:  Lorne Holland; Theodore E Warkentin; Majed Refaai; Mark A Crowther; Marilyn A Johnston; Ravindra Sarode
Journal:  Transfusion       Date:  2009-02-06       Impact factor: 3.157

3.  Recommendations for the use of antithrombin concentrates and prothrombin complex concentrates.

Authors:  Giancarlo Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2009-10       Impact factor: 3.443

4.  Prothrombin complex concentrates for urgent anticoagulation reversal in patients with intracranial haemorrhage.

Authors:  D Imberti; G Barillari; C Biasioli; M Bianchi; L Contino; R Duce; M D'Incà; L Mameli; L Pinna; W Ageno
Journal:  Pathophysiol Haemost Thromb       Date:  2009-12-09

5.  Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies.

Authors:  M Cartmill; G Dolan; J L Byrne; P O Byrne
Journal:  Br J Neurosurg       Date:  2000-10       Impact factor: 1.596

Review 6.  Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.

Authors:  Michael Makris; Joost J van Veen; Rhona Maclean
Journal:  J Thromb Thrombolysis       Date:  2010-02       Impact factor: 2.300

7.  Impact of infusion speed on the safety and effectiveness of prothrombin complex concentrate: a prospective clinical trial of emergency anticoagulation reversal.

Authors:  Ingrid Pabinger; Andreas Tiede; Uwe Kalina; Sigurd Knaub; Reinhard Germann; Helmut Ostermann
Journal:  Ann Hematol       Date:  2009-09-29       Impact factor: 3.673

Review 8.  Prophylaxis of bleeding episodes and surgical interventions in patients with rare inherited coagulation disorders.

Authors:  Giancarlo Castaman
Journal:  Blood Transfus       Date:  2008-09       Impact factor: 3.443

9.  Influence of prothrombin complex concentrates on plasma coagulation in critically ill patients.

Authors:  T Staudinger; M Frass; C Rintelen; P Quehenberger; O Wagner; B Stoiser; G J Locker; K Laczika; S Knapp; H Watzke
Journal:  Intensive Care Med       Date:  1999-10       Impact factor: 17.440

10.  Prothrombin complex concentrate (Beriplex P/N) in severe bleeding: experience in a large tertiary hospital.

Authors:  David Bruce; Tim J C Nokes
Journal:  Crit Care       Date:  2008-08-15       Impact factor: 9.097
View more
  43 in total

Review 1.  Clinical use and the Italian demand for prothrombin complex concentrates.

Authors:  Massimo Franchini; Giancarlo M Liumbruno; Monica Lanzoni; Fabio Candura; Stefania Vaglio; Samantha Profili; Giuseppina Facco; Gabriele Calizzani; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

2.  eComment. Anticoagulation after intracranial haemorrhage in patients with a high risk of thrombosis.

Authors:  Leo A Bockeria; Alexey A Kupryashov
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-04

3.  Appropriate timing to start and optimal response evaluation of high-dose corticosteroid therapy for patients with acute liver failure.

Authors:  Keisuke Kakisaka; Kojiro Kataoka; Yuji Suzuki; Hidekatsu Kuroda; Yasuhiro Takikawa
Journal:  J Gastroenterol       Date:  2017-01-11       Impact factor: 7.527

4.  Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding.

Authors:  D Imberti; A Magnacavallo; F Dentali; E Condoleo; M Gallerani; R Benedetti; W Ageno
Journal:  J Thromb Thrombolysis       Date:  2013-07       Impact factor: 2.300

Review 5.  Rendering factor Xa zymogen-like as a therapeutic strategy to treat bleeding.

Authors:  Nabil K Thalji; Rodney M Camire
Journal:  Curr Opin Hematol       Date:  2017-09       Impact factor: 3.284

Review 6.  Effectiveness of prothrombin complex concentrate (PCC) in neonates and infants with bleeding or risk of bleeding: a systematic review and meta-analysis.

Authors:  Linan Zeng; Imti Choonara; Lingli Zhang; Youping Li; Jing Shi
Journal:  Eur J Pediatr       Date:  2017-03-09       Impact factor: 3.183

Review 7.  Prothrombin Complex Concentrates for Bleeding in the Perioperative Setting.

Authors:  Kamrouz Ghadimi; Jerrold H Levy; Ian J Welsby
Journal:  Anesth Analg       Date:  2016-05       Impact factor: 5.108

Review 8.  Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: A Statement for Healthcare Professionals from the Neurocritical Care Society and Society of Critical Care Medicine.

Authors:  Jennifer A Frontera; John J Lewin; Alejandro A Rabinstein; Imo P Aisiku; Anne W Alexandrov; Aaron M Cook; Gregory J del Zoppo; Monisha A Kumar; Ellinor I B Peerschke; Michael F Stiefel; Jeanne S Teitelbaum; Katja E Wartenberg; Cindy L Zerfoss
Journal:  Neurocrit Care       Date:  2016-02       Impact factor: 3.210

Review 9.  Prothrombin Complex Concentrates are Superior to Fresh Frozen Plasma for Emergency Reversal of Vitamin K Antagonists: A Meta-Analysis in 2606 Subjects.

Authors:  Robert Hill; Thang S Han; Irina Lubomirova; Nikhil Math; Paul Bentley; Pankaj Sharma
Journal:  Drugs       Date:  2019-09       Impact factor: 9.546

Review 10.  Reversal of oral anticoagulation.

Authors:  Jonathan L Thigpen; Nita A Limdi
Journal:  Pharmacotherapy       Date:  2013-04-18       Impact factor: 4.705
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.